Virtual Event | May 27, 2022

What Risks Does EU (536/2014) Pose To Your Trials?

In January 2022, major changes came to the way clinical trials are conducted in the European Union. EU (536/2014) came into effect and is a binding regulation across all members of the EU. The new regulation will streamline procedures and remove duplication single submission via a single EU portal. It also focuses on an assessment procedure leading to a single decision, rules on the protection of subjects and informed consent, a greater level of harmonization, and transparency requirement.

However, there are issues sponsor companies should be concerned about. Check out this On-Demand presentation from Clinical Leader Live to learn about the shortcomings of the regulation, challenges that can arise from it, how technology solutions can play a greater role in trials, why the regulation will require coordinated efforts, and what companies can do to avoid delays in the launch of multi-country clinical studies.

VIEW THE VIRTUAL EVENT!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: